Carcinoembryonic antigen (CEA) and carbohydrate antigen 125 (CA125) can also be used to guide diagnosis and treatment selection and as indicators of treatment efficacy for lung cancer [14, 15]. The gene discussed is CEACAM5; the disease is lung cancer.